Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 March 2005, Vol. 105, No. 6, pp. 2245-2246.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oldenborg, P.-A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Oldenborg, P.-A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

IMMUNOBIOLOGY

Comment on Piccio et al, page 2421

CD47 and SIRPs: new openings

Per-Arne Oldenborg

UMEÅ UNIVERSITY

In the present issue of Blood, Piccio and colleagues report that a member of the signal-regulatory protein (SIRP) family, SIRP{beta}2, is expressed by T cells, binds to CD47, and costimulates T-cell proliferation.

Within the SIRP family of cell-surface glycoproteins, SIRP{alpha} and SIRP{beta}1 have hitherto been identified and studied. SIRP{alpha} is highly expressed by myeloid cells and neurons, but expression has also been found on endothelial cells and a subpopulation of B cells. In myeloid cells, SIRP{alpha} has been reported to inhibit phagocytosis and cytokine production when ligated by its ubiquitously expressed cell-surface ligand CD47, a function mediated by the cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs) of SIRP{alpha}.1,2 The CD47-SIRP{alpha} interaction can also support cell-cell adhesion and cell migration. SIRP{beta}1, on the other hand, does not have any intracellular signaling motifs of its own, but functions by signaling through recruitment of the adaptor protein DAP12, resulting in stimulation of myeloid cellular functions.3 In contrast to SIRP{alpha}, SIRP{beta}1 does not seem to bind CD47.4

The present report on SIRP{beta}2 significantly extends the understanding of this family of receptors, showing that SIRP{beta}2, in contrast to SIRP{alpha} and SIRP{beta}1, is not expressed by myeloid cells, but rather by T cells and activated natural killer (NK) cells. Similar to SIRP{alpha}, SIRP{beta}2 binds CD47 on other cells, in this case antigen-presenting cells (APCs). However, the CD47 binding affinity is lower for SIRP{beta}2 than that for SIRP{alpha}. The cytoplasmic domain of SIRP{beta}2 does not have ITIM motifs or the capacity to bind DAP12. Instead, the authors suggest that the SIRP{beta}2-CD47 interaction may function to strengthen the T-cell–APC binding, thereby supporting T-cell activation. These data are supported by a recent report, where the SIRP{beta}2 protein was referred to as SIRP{gamma}, and shown to bind CD47.5 That study showed that, by binding to CD47, both SIRP{beta}2/SIRP{gamma} and SIRP{alpha} fusion proteins could induce CD47-dependent apoptosis in CD47-expressing cells.5

The present findings raise new, interesting questions about the ability of CD47 to regulate immune reactions by binding to SIRP{alpha} and SIRP{beta}2. Although the APCs in the present study were B cells, which may not express SIRP{alpha}, other important APCs such as dendritic cells and macrophages express this receptor. Bidirectional signaling following binding of CD47 on the T cell to SIRP{alpha} on the APC was reported to inhibit both T-cell and APC activation.2 However, it has also been shown that this interaction might have the opposite effect, resulting in costimulation of T-cell activation.1,4 Since the CD47-SIRP{alpha} interaction could theoretically operate in parallel with the SIRP{beta}2-CD47 interaction reported by Piccio et al (see figure), further investigations are needed to understand how these interactions can regulate T cells and APCs in various settings of immune activation. {blacksquare}



Possible effects of dual interactions between CD47-SIRP{alpha} and CD47-SIRP{beta}2 upon contact between T cells and APCs.

 

References

  1. Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 2001;11: 130-135.[CrossRef][Medline] [Order article via Infotrieve]

  2. Latour S, Tanaka H, Demeure C, et al. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulatory protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol. 2001;167: 2547-2554.[Abstract/Free Full Text]

  3. Hayashi A, Ohnishi H, Okazawa H, et al. Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages. J Biol Chem. 2004;279: 29450-29460.[Abstract/Free Full Text]

  4. Seiffert M, Brossart P, Cant C, et al. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood. 2001;97: 2741-2749.[Abstract/Free Full Text]

  5. Brooke G, Holbrook JD, Brown MH, Barclay AN. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J Immunol. 2004;173: 2562-2570.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Adhesion of human T cells to antigen-presenting cells through SIRP{beta}2-CD47 interaction costimulates T-cell proliferation
Laura Piccio, William Vermi, Kent S. Boles, Anja Fuchs, Carey A. Strader, Fabio Facchetti, Marina Cella, and Marco Colonna
Blood 2005 105: 2421-2427. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oldenborg, P.-A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Oldenborg, P.-A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020